Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.

Sørensen B, Benson GM, Bladen M, Classey S, Keeling DM, McLaughlin P, Yee TT, Makris M.

Haemophilia. 2012 Jul;18(4):598-606. doi: 10.1111/j.1365-2516.2011.02720.x.

PMID:
22151135
2.

Muscle bleeds in professional athletes--diagnosis, classification, treatment and potential impact in patients with haemophilia.

Beyer R, Ingerslev J, Sørensen B.

Haemophilia. 2010 Nov;16(6):858-65. doi: 10.1111/j.1365-2516.2010.02278.x. Review.

PMID:
20491962
3.

Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre.

Ashrani AA, Osip J, Christie B, Key NS.

Haemophilia. 2003 Nov;9(6):721-6.

PMID:
14750939
4.

Current practice in the management of muscle haematomas in patients with severe haemophilia.

Beyer R, Ingerslev J, Sørensen B.

Haemophilia. 2010 Nov;16(6):926-31. doi: 10.1111/j.1365-2516.2010.02275.x.

PMID:
20491963
5.

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression.

Treur MJ, McCracken F, Heeg B, Joshi AV, Botteman MF, De Charro F, Van Hout B.

Haemophilia. 2009 Mar;15(2):420-36. doi: 10.1111/j.1365-2516.2008.01956.x. Review.

PMID:
19335751
6.

Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.

Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E.

Thromb Haemost. 1998 Dec;80(6):912-8.

PMID:
9869160
7.

Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE).

Young G, Shapiro AD, Walsh CE, Gruppo RA, Gut RZ, Cooper DL.

Haemophilia. 2012 May;18(3):392-9. doi: 10.1111/j.1365-2516.2011.02704.x.

PMID:
22171621
8.

Meeting unmet needs in inhibitor patients.

Blanchette VS, Manco-Johnson MJ.

Haemophilia. 2010 May;16 Suppl 3:46-51. doi: 10.1111/j.1365-2516.2010.02260.x.

PMID:
20586802
9.

The need for speed in the management of haemophilia patients with inhibitors.

Salek SZ, Benson GM, Elezović I, Krenn V, Ljung RC, Morfini M, Remor E, Santagostino E, Sørensen B.

Haemophilia. 2011 Jan;17(1):95-102. doi: 10.1111/j.1365-2516.2010.02265.x.

PMID:
20398071
10.

Treatment of muscle haematomas in haemophiliacs with special emphasis on percutaneous drainage.

De la Corte-Rodriguez H, Rodriguez-Merchan EC.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):787-94. doi: 10.1097/MBC.0000000000000159. Review.

PMID:
24914744
11.

Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.

Petrini P, Klementz G.

Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S143-6.

PMID:
9819046
12.

Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.

Nagel K, Walker I, Decker K, Chan AK, Pai MK.

Haemophilia. 2011 Nov;17(6):872-4. doi: 10.1111/j.1365-2516.2011.02506.x.

PMID:
21342368
13.

Guideline for the treatment of haemophilia in South Africa.

Mahlangu JN, Gilham A; Medical and Scientific Advisory Council of the South African Haemophilia Foundation..

S Afr Med J. 2008 Feb;98(2 Pt 2):126-40.

PMID:
18453313
14.

Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.

Chuansumrit A, Isarangkura P, Angchaisuksiri P, Sriudomporn N, Tanpowpong K, Hathirat P, Jorgensen LN.

Haemophilia. 2000 Mar;6(2):61-5.

PMID:
10781189
15.

The overall effectiveness of prophylaxis in severe haemophilia.

Panicker J, Warrier I, Thomas R, Lusher JM.

Haemophilia. 2003 May;9(3):272-8.

PMID:
12694517
16.

FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations.

Perry D, Berntorp E, Tait C, Dolan G, Holme PA, Laffan M, Lassila R, Mumford A, Pasi J, Wilde J, Will A, Yee TT.

Haemophilia. 2010 Jan;16(1):80-9. doi: 10.1111/j.1365-2516.2009.02104.x.

PMID:
19780845
17.

Musculoskeletal problems in persons with inhibitors: how do we treat?

Caviglia H, Narayan P, Forsyth A, Giangrande P, Gilbert M, Goddard N, Mulder K, Rahim S.

Haemophilia. 2012 Jul;18 Suppl 4:54-60. doi: 10.1111/j.1365-2516.2012.02874.x. Review.

PMID:
22726084
18.

A retrospective postlicensure survey of FEIBA efficacy and safety.

Dimichele D, Négrier C.

Haemophilia. 2006 Jul;12(4):352-62.

PMID:
16834734
19.

Prophylaxis for severe haemophilia: clinical and economical issues.

Fischer K, Van Den Berg M.

Haemophilia. 2003 Jul;9(4):376-81.

PMID:
12828671

Supplemental Content

Support Center